Etiracetamum Uses, Dosage, Side Effects and more
Etiracetamum is under investigation in clinical trial NCT01137110 (Comparison of Short Duration Levetiracetam to Extended Course for Seizure Prophylaxis After Subarachnoid Hemorrhage (SAH)).
| Trade Name | Etiracetamum |
| Generic | Etiracetam |
| Etiracetam Other Names | Etiracetam, étiracétam, Etiracetamum |
| Type | |
| Formula | C8H14N2O2 |
| Weight | Average: 170.212 Monoisotopic: 170.105527699 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
